Long-term effectiveness of adjuvant treatment with catechol-O-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson disease uncontrolled by Levodopa Therapy: the PD MED randomized clinical trial
Research output: Contribution to journal › Article › peer-review
39Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Long-term effectiveness of adjuvant treatment with catechol-O-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson disease uncontrolled by Levodopa Therapy: the PD MED randomized clinical trial'. Together they form a unique fingerprint.